Short answer
Tempus AI Inc (TEM) filed an 8-K current report with the SEC on July 20, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). Merger agreement signed July 20, 2026, with Personalis becoming a wholly owned Tempus subsidiary, expanding Tempus’ precision oncology capabilities.
Tempus AI Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Merger agreement signed July 20, 2026, with Personalis becoming a wholly owned Tempus subsidiary, expanding Tempus’ precision oncology capabilities
- Consideration targets $16.25 per Personalis share, payable in Tempus stock, with cash election for up to 50% of shares
- Exchange ratio protected by a $48.42 Tempus floor, fixed at 0.3356 shares below that price
- Personalis may terminate if Tempus stock falls below $46.00 near closing, creating downside execution risk for Tempus shareholders
- Closing requires Personalis shareholder approval, Nasdaq listing, Form S-4 effectiveness and antitrust clearance, with an April 20, 2027 outside date
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tempus AI Inc 8-K filings
Get the next TEM 8-K as it lands
Follow TEM for push alerts, or ask the research agent what this filing means.